In conclusion, our data demonstrate that miR-17-19b sustains homeostasis of MYC-driven lymphomas by fine-tuning MYC expression, thus protecting tumour cells from harmful effects linked to excessive MYC levels. The gene discussed is MYC; the disease is lymphoma.